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ABSTRACT
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Under the Supervision of Professor Ramin Pashaie

Direct neural stimulation has recently become a standard therapy for neurological
disorders such as Parkinson’s Disease, Essential Tremors, and Dystonia. Currently, deep
brain electro-stimulation and neuro-pharmaceutical treatments are the dominant
therapeutic options available to the public. As our understanding of brain function and
neurological diseases improves, we are able to develop more advanced neuromodulation
techniques. These methods could become viable treatment solutions for treating brain
dysfunction. Optogenetics, first introduced by a research team led by Karl Deisseroth at
Stanford University, has proved to be a versatile technique with remarkable potential to
be used in treatments for brain disorders, dysfunction, and injuries. Optogenetics makes
use of light-gated ion channels and pumps, originally derived from certain types of algae
or bacteria, to bi-directionally modulate the activity of neurons in mammals. By adopting
new advances in the field of optics and photonics, including high-speed high-resolution
spatial light modulators, solid-state lasers, and ultra-low noise photodetectors, we can
build sophisticated devices which allow precise and resolute optical patterning in both the
spatial and temporal domains.
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In this thesis, I present an optogenetic brain-machine interface that offers high
spatiotemporal neuromodulation functionality. The incorporation of imaging and sensing
devices of neural activity into the system allowed us to run multiple independent
experiments. These optogenetic experiments include closed-loop modulation of multiple
areas of tissue, investigating the causal relationship between neural activity and blood
flow, and quantifying the relationship between neural activity and cell metabolism.
To understand light to brain tissue interaction in a rat brain, a device has been
developed which allows one to extract the optical properties throughout the tissue.
Utilizing this data, Monte Carlo software was used to predict light distribution within the
brain. This has far reaching effects for the future use of optogenetics. Our approach will
allow the investigator the ability to precisely understand how introduced light will be
distributed within the rat brain where light-gated ion channels have been genetically
expressed. This becomes noticeably important when attempting to determine which areas
of the brain tissue will and won’t be modulated by the introduced light.
Due to the many advantages optogenetics inherently provides, it is a rising
prospect for novel neuromodulation therapies. With continued research and development
of devices, we could create new therapies for disabilities that arise from dysfunction of
the human brain.
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Chapter I.

Introduction

1. Why invest in brain research?
The human brain is an extremely complex organ. The brain consists of
approximately 100 billion neurons, and each of these neurons can have thousands of
connections [1]. Attempting to understand brain function and connections are daunting
tasks. Scientists’ efforts could potentially yield invaluable information, which may
impact our lives greatly. It seems that a large collaboration of highly dedicated scientists
is the only feasible solution to understanding how this biological computer functions. In
2012, both the United States [2] and European Union [3] announced programs investing
large amounts of funding towards understanding the brain function, connections,
processing, and computational brain algorithms. These initiatives were announced
independently; however, due to the complexity of the human brain, most likely these
programs will become interdependent.
These initiatives are designed around the successful “Human Genome Project” [4]
which not only completed the project goals but exceeded the expectations and had many
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unforeseeable benefits. Financially, the economic impact was substantial. For every $1
the US government invested the program returned $141 [5]. The initiative accelerated our
understanding of Genomics and it also allowed for developments related to bioinformatics, and aided in research across many fields in medicine and biology.
With 1 billion people affected by neurological diseases worldwide [6] investing in
brain research seems imperative. Not only will investing in brain research help people
suffering from neurological disorders, but it will open new doors for creating complex
processing algorithms, intelligent machines, or inventing new architectures for complex
parallel processing units. The brain is a parallel, non-linear processing organ capable of
cognition. Understanding how our brain is able to understand our surrounding
environment will benefit humanity greatly, possibly with greater impact compared with
the human genome project.

2. Why develop Brain-Machine Interfacing devices?
The relatively recent computer boom has brought about new opportunities which
aid in scientist's attempts to understand the human brain. Today, we have a better
understanding of computation and processing than in the past. Using the innovations of
computers and programming we have developed algorithmic models of neural networks,
neural circuits, and brain function which have helped in our quest to understand the brain.
Even with these algorithmic models, scientists still lack a fundamental understanding of
human brain function. This disconnection inhibits our ability to cure or treat brain
disorders and dysfunctions, directly investigate biological networks and circuits in-vivo
and in-vitro, or to interface directly with our powerful information processing organ
which is responsible for our well-being.
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Using technology and our understanding of the brain, scientists are developing
tools that are used to understand, communicate, and aid our brains. These brain-machine
interface devices, which interface or communicate with the brain, have opened many new
research opportunities and medical treatments that were extremely challenging if not
impossible before.

3. Biological Inspired Sciences and Technologies Lab
Here at BIST labs, we devote our time developing tools which help us understand
the brain and other biological processes as well as understanding the engineering
principles adapted for realization of these tools. BIST lab employs the new technique of
Optogenetics, explained later in this thesis, with a goal of furthering our understanding of
neural circuitry and brain function. BIST lab’s collaborators are experts in imaging,
neuroprosthetics, and neuroscience and through our collaborations we create devices that
potentially aid in brain research.
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Chapter II.

Background

1. Neural Function
The brain is a collection of neurons (electrochemical non-linear biological
processing cells), which when combined in complex networks with coded data, form the
ability to understand their surroundings and adapt to win the evolutionary game of life.
This is a very short yet complex description of the brain. We should start our journey by
understanding how a single neuron functions.
In order to understand the most complex processes of the brain we must first
understand the most fundamental discoveries that explain how a neuron functions. Ions,
ion channels and pumps, and the membrane potential are all involved in neurons
function. We should understand these elements to construct our understanding of neuron
function.
Ions, ion channels and pumps, the cell membrane, the membrane potential, and
how these elements work together to create the non-linear function of a neuron are an
important part of understanding how the brain processes information. Inside and outside
neurons there is a fluid that consists of many positively and negatively charged ions. In
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this thesis we will think of ions as point charges, points in space of some positive or
negative integer value charge. The difference of the net charge of ions inside the cell
compared to outside of the cell is called the membrane potential. There are many
pathways or gates located within the cell membrane for these charged ions to enter and
leave a neuron. We call these pathways ion channels and ion pumps.
A. Ion Channels and Pumps
Ion channels are regulated by different mechanisms within the human brain.
Naturally occurring regulators called neurotransmitters are able to open and close
transmitter-gated ion channels by binding to neuroreceptors. Alternatively, channels can
be opened or closed by voltage dependent mechanisms. These voltage dependent
mechanisms are triggered by specific cell membrane threshold voltages. Certain
threshold voltages are reached by the concentrated amounts of ions inside or outside the
cell. This alters the cells membrane potential and triggers the opening or closing of the
voltage gated ion channel. Transmitter-gated ion channels and pumps are generally
involved in transferring a signal from a pre-synaptic neuron to a post-synaptic neuron or
the transfer of signals between neurons. Voltage gated channels are responsible for the
transfer of a signal within a neuron and triggering the release of neurotransmitters at the
axon terminals.
B. Membrane potential
In order to better understand the function of a membrane potential, we imagine
that there are three states in which the membrane potential may exist: a resting state, a
firing state, and a restoring state. Refer to Figure 1 for a visual representation of these
states with respect to a neuron's membrane potential.
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C. Resting state
The resting state is the condition in which the ion concentration inside compared
to outside the cell has reached equilibrium. At this point, the neuron is ready to receive
input stimulation from other neurons. These connecting neurons either help to depolarize
(raise the membrane potential) or hyperpolarize (lower the membrane potential) by
interacting with the transmitter-gated ion channels located in the neuron’s synaptic sites.
The dendrites of a neuron may be connected to thousands of neighboring neurons. These
neighboring neurons have a collective effect on the neuron's membrane potential.
Neighboring cells can either help to depolarize the cell membrane, bringing the cell
closer to the threshold voltage, or can help to hyperpolarize the cell membrane, keeping
the cell membrane potential lower than the threshold voltage. As the membrane potential
rises due to neighboring cell inputs, it will eventually reach a threshold voltage required
to open the voltage gated ion channels.
D. Action state
When the membrane potential reaches the threshold voltage, the voltage gated
sodium ion channels open allowing a large influx of sodium ions through the cell
membrane. After a short period, the slower potassium ions start to open causing an
outflux of potassium ions. The resulting spike in the membrane potential is called an
action potential. The duration of an action potential is about 1ms. This action potential
initiates at axonal hillock and propagates along the axon out to the axon terminals. At this
point, synapses, located at the ends of the axon terminals, release neurotransmitters in
order to pass this signal to its neighboring neurons.
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Figure 1 - A) Image of neuron anatomy. Dendrites receive inputs from connected neurons, the axon is a
pathway for a neural signal to move from the soma to the axon terminals, the axon terminals and
synapses are where signal transfer between neurons takes place. B) This is a visualization of the
membrane potential during the Resting State and the Action State. C) Dendritic inputs are the source of
inter-neuron communication. The charges of ions entering a neuron as dendritic inputs are cumulative.
D) Dynamics of the voltage gated ion channels, potassium and Sodium. As the membrane potential
reaches a threshold voltage, voltage gated ion channels open, causing a spike in the neuron's membrane
potential called an action potential. The opening dynamics of these ion channels are the main source of
the action potentials distinct shape. Sodium channels open fast causing an influx of positive ions.
Potassium channels open and close slower causing outflux of positive ions. When combining the two
channel dynamics, the net change in ions creates the action potential. Parts of figure adapted from [60]
and [61]

Directly after this voltage spike, there is a period of time when the voltage gated
ions are closing and the membrane potential is being restored to the neuron's resting
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potential (about -65mV). After the neuron returns to its resting potential, the resting state
of a neuron's membrane potential begins to have an effect on the membrane potential.
E. Neurotransmitters and communication between neurons
A post-synaptic neuron is a neuron that has formed a connection through its cell
body, dendrite, or axon with a pre-synaptic neuron. Neurotransmitters are released from
the synapse of a pre-synaptic neuron, after an action potential, into the synaptic cleft
where they are free to bind to neuroreceptors located on the post-synaptic neuron. Each
type of neurotransmitters bind only to specific neuroreceptors. As these neurotransmitters
bind with their respective neuroreceptors, the state of the transmitter-gated ion channel
changes and directly affects the ion concentrations within the post-synaptic neuron. This
change impacts the neuron's membrane potential, and thus the neuron’s activity.
Neurons can be excitory neurons or inhibitory neurons depending on the types of
neurotransmitters they produce. Excitory neurons, when transferring a signal, release
neurotransmitters that create a flux of ions which have a depolarizing effect on the postsynaptic neuron. This flux of ions raises the membrane potential, bringing it closer to
threshold voltage required for an action potential. Inhibitory neurons, when chemically
transferring a signal, release neurotransmitters that create a flux of ions which have a
hyperpolarizing effect on the post-synaptic neuron. This flux of ions reduces the
membrane potential and keeps it further away from the threshold voltage required for the
generation of an action potential. Both of these neuron types can be part of large groups
of interconnected neurons called neural networks.
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2. Neural Networking
Networks of neurons are self-organizing connections between many neurons
which, when organized in a particular way, create a data processing apparatus. These
networks are presented with an input signal that, as it propagates through the network, is
filtered or coded. The connections in a network of neurons may change over time; this
ability to change over time is called neural plasticity. These changes can occur because of
environmental factors, injuries, change in lifestyle, etc. Network function can range from
simple edge detection within the visual cortex to complex face recognition and motor
functions.
Neural networks start their processing using sensory inputs from our sensory
organs: visual, somatosensory, auditory, gustatory, and olfactory. Each of these sensory
systems has cells or mechanisms that quantify their specific sense. The visual system uses
light sensitive cells called photoreceptors, which are present as either rods or cones, to
quantify photons into neural signals. The auditory mechanism is a collective structure of
separated air chambers, tiny bones and membranes which are able to separate and
quantify air pressure waves into their frequency components. The quantification of these
sensory inputs now becomes inputs to neural networks.
Each sensory input travels through distinct pathways in the brain. As the signal
propagates through these pathways the input is processed. This processing extracts
information from the inputs, which our brain uses to classify our surrounding world.
These information-processing networks are complex combinations of cells, which have a
remarkable ability to collectively understand our surroundings through our sensory
inputs.
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In order to understand complex networks, we must first understand the simple
microcircuits that occur within the brain. These microcircuits are the interactions between
different types of neurons (for example inhibitory and excitory) and different connections
between them. These distinct microcircuits are considered the building blocks of large
networks within the brain as they combine and expand to create complex networks with
specific functions. These complex networks are what enable us to extract and remember
information from our surrounding environment in order to make decisions.
Some possible building block microcircuits, or micronetwork motifs are described in
Figure 2.
Expanding upon and combining these simple microcircuits allow for the
development of highly connected and complex networks with specific function. One
example of the function of these complex networks is edge detection which is used
extensively in our visual system.

3. Temporal Firing Rates and Frequency Coding
Frequency coding or rate coding refers to the phenomenon of information being
represented within the frequency of neural spikes. An experiment conducted by E. D.
Adrian, where he stimulated the sterno-cutaneus muscle in a medium sized frog, to
demonstrate that the frequency of nerve impulses increased as the force on the muscle
increased [7]. 0.5 grams resulted in a frequency of 35 impulses per second directly after
loading and after 10 seconds of loading it reduced to 15 impulses per second. 1 gram
resulted in 66 impulses per second directly after loading and after 10 seconds of loading
it reduced to 37.5 impulses per second. How information is coded within the brain is still
an active area of research but it is important for us to remember that information from our

11

surroundings are coded into signals which become the inputs for the neural networks
within our brains.

Figure 2 - Description of possible microcircuits made by combining Inhibitory, excitory, and different
types of connections between them. This figure is adapted from figure 6 in citation [62]
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4. Neurons and Oxygen
Oxygen is crucial to the health of brain cells and these cells receive oxygen
contained in blood that comes from our lungs. Oxygenated blood is so important to
functioning brains that our bodies will redirect blood flow to the brain in a case of
lowered blood oxygen levels. The brain requires approximately 3.3 mL of oxygen per
100 g of brain tissue per minute [8]. This is roughly 17.82% of our total oxygen
consumption (Average brain weight *Oxygen consumption per 100 grams brain mass).
This means that approximately 2.18% of our body weight (Average brain weight/Average
human body weight) consumes 17.82% of our blood oxygen.
A widely accepted relationship between neural activity and oxygen consumption
is that as neural activity increases, oxygen consumption also increases [9]. This
relationship has become extremely important in brain research due to our ability to
monitor blood oxygenation easier then monitoring brain activity directly. Functional
magnetic resonance imaging (fMRI) is a widely used device for monitoring blood
oxygenation by measuring the blood oxygenation level dependent (BOLD) signal.

5. Neurons and Metabolism
The brain needs energy to function! More specifically, the brain needs glucose to
power its function. Glucose can be incorporated into lipids, proteins, glycogen, and is
also the precursor of certain neurotransmitters. The brain accounts for 25% of our body’s
glucose utilization [10]. Just as with oxygen, scientists have formed a connection between
neural metabolism and neural activity. A widely accepted relationship between neural
activity and metabolism is that as neural activity increases, metabolism in turn increase.
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6. Introduction to Neural Modulation
An important technique that can be used to investigate neural circuitry is
neuromodulation. We consider neuromodulation as a technique used to control or
modulate the activity of neurons using an externally controlled source. Today, scientists
have developed many different types of neuromodulation techniques. These techniques
use our understanding of neuron function to cause an increase or decrease in neuron
activity. Having the ability to precisely control the activity of neurons and neural tissue
allows us the opportunity to correct dysfunction within neural networks in our brains
[11]. Neuromodulation allows scientists to study the functions of specific areas of neural
tissue. For example, by stimulating different areas of the motor cortex, scientists have
developed detailed relational maps between motor (movement) actions and areas of
neural tissue in the motor cortex [12]. Our understanding of brain function seems reliant
on our ability to modulate neural tissue. Ideally, a neuromodulation technique would have
a spatial resolution below the size of a neural cell allowing for spatial targeting in the
cellular range, and a temporal range of stimulation in the range of a single action
potential.
A. Electrical Modulation Technique
One well-known and widely used technique for modulation of neural tissue is
electrical stimulation. Scientists use our understanding of electric charge to interact with
neural membrane potentials. By introducing an electrode of negative charge in an area of
neural tissue, researchers can stimulate neurons in the surrounding area. Researchers have
created many different arrays of electrodes with varying size, number of electrodes,
penetrating and surface mount electrodes, compositions, and electrical designs. While
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this technique has been used nearly exclusively throughout history for neural experiments
and treatments for brain disorders, there are many limitations of electrode arrays.
Electric stimulation can only directly stimulate areas of neural tissue. In order to
inhibit areas of neural tissue, researchers must indirectly cause inhibition by stimulating
inhibitory neurons. This seems problematic for neural probing as our knowledge of
specific neural connections is still vastly unknown. Implanting electrodes into neural
tissue also poses problems such as damage to tissue, infections, and even our immune
systems can hinder electrode effectiveness. The sizes of electrode arrays are limited by
manufacturing processes and also by the amount of damage they cause to the neural
tissue when implanted. Another issue is that electrode arrays have low spatial resolution
compared to the size of neurons.
B. Optogenetics – An optical Neural Modulation Technique
In 2005, a new technique developed for neural modulation, Optogenetics [13],
was introduced by the Deisseroth lab at Stanford University. Using genetic techniques,
Karl Deisseroth and his lab members were able to successfully express DNA, originally
found in algae, in mammalian neurons. The expressed DNA includes the genetic code or
instructions for a cell to produce specific opsins. These opsins are light sensitive
receptors which were used by the algae to sense their source of energy. In neurons, these
opsins are used to modulate the activity of neurons with light. I will present two specific
opsins in this thesis, a light-gated cation channel, Channelrhodopsin-2 (ChR2), and a
light-driven chloride pumping halorhodopsin (NpHR). ChR2, when exposed to light of
approximately 445nm wavelength (Refer to Figure 3 for a more detailed spectrum of
stimulation wavelengths for ChR2), allows Na+ and Ca+ into the cell which raises or
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depolarizes the membrane potential and leads to an action potential. NpHR, when
exposed to light of approximately 570nm wavelength, pumps chloride ions into the cell
which hyperpolarizes the membrane potential thus inhibiting the neuron from firing
(Refer to Figure 3 for a more detailed spectrum of stimulation wavelengths for NpHR).
ChR2 and NpHR allow for stimulation and inhibition of genetically targeted
neural populations on the millisecond timescale [14]. In Figure 3(C), you find an
experimental demonstration of both ChR2 (neural stimulation) and NpHR (neural

Figure 3 - A) Left image shows channelrhodopsin-2 (ChR2), Right image shows halorhodopsin (NpHR).
+
ChR2 allows Na into the cell when activated by blue light. NpHR pumps Cl into the cell when
activated by yellow light. B) Spectral activation of ChR2 and NpHR. Given the maximum locations for
both are located approximately 100nm from eachother, it is possible to simultaneously stimulate
using ChR2 while inhibit using NpHR C) Experimental demonstration of both stimulation using ChR2
and inhibition using NpHR. This figure is directly adapted from “Circuit-breakers: optical technologies for
probing neural signals and systems.” [63]
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inhibition). In Figure 3, we notice that NpHR is able to suppress neural action potentials
even when cells are stimulated with ChR2 and blue light. The development of novel
optical devices allows for large scale neural network probing with high spatial and
temporal resolution. The optogenetic technique allows for cell-type specific targeting
[15] by using appropriate promoters. Another unique benefit of optogenetics is having the
ability to bi-directionally control the cellular activity of neurons directly. By having the
ability to express both light-gated cation channels and light-gated anion pumps into
neurons simultaneously, one has the ability to either increase neural activity or suppress
neural activity [14][16]. Another benefit of using light as the source for activating the ion
channels lies within our ability to manipulate light to form images or patterns which are
both temporally and spatially dependent. In this thesis, I will introduce such a device for
patterning stimulating light with megapixel resolution and the ability to target specific
areas contained within the field of view.

7. Introduction to Neural Monitoring
Just as important to neuromodulation for investigating neural circuitry is having
the ability to monitor neural activity or something that indicates neural activity. Current
techniques and devices used in monitoring neural activity vary widely in both temporal
resolution as well as spatial resolution. Not only do these techniques vary in resolution
but they also vary in what specifically they monitor. These monitoring devices measure
oxygen in blood, the metabolism of cells and tissue, local field potentials, actual
membrane potential of a neuron, or even the concentrations of calcium inside of a neuron.
Through years of research and investigation of neural function, scientists have developed
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and/or are still developing relationships between these neural activity indicators and
neural activity.
The functional Magnetic Resonance Imaging (fMRI) technique uses a relation
between a blood oxygen-level dependent (BOLD) signal and neural activity. Functional
MRI has become a monitoring device which dominates brain research. Functional MRI
has acceptable spatial resolution with the ability to monitor the whole human brain.
Functional MRI has a relatively low temporal resolution mainly due to the nature of
blood flow within the brain and how blood flow changes in response to neural activity.
Positron Emission Tomography (PET) monitors the metabolism of neural tissue and uses
a relationship established between metabolism and neural activity. As neurons are more
active, the energy usage increases thus metabolism increases. PET machines use this
intertwined relationship to image brain activity. Electroencephalography (EEG) and
Electrocorticography (ECoG) both measure local field potentials (LFP) or collections of
neural activity. EEG measures LFPs from the surface of the scalp while ECoG arrays are
implanted directly onto the surface of the brain from where they measure LFPs
originating in the cerebral cortex. Spatial resolution of ECoG is better than EEG's
resolution because are placed closer to the brain tissue. The membrane potential of a
neuron can be measured using a technique called patch clamping. The patch clamp
technique measures the membrane potential by placing one electrode inside the cell while
having another electrode just outside the cell. The difference between the electric
potential recorded by these electrodes is the membrane potential. Fluorescence imaging
allows for measuring changes in metabolism, blood flow, and even concentrations of
specific ions within neurons. This type of imaging is versatile and has been used for
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many applications. Pairing fluorescence imaging with neural modulation techniques
offers additional advantages such as targeting the activity of specific cell types.

8. Introduction to Brain-Machine Interfacing
A brain-machine interface (BMI) is a device which interfaces directly with brain.
There are three possible interactions that can be implemented via BMI application. These
interactions are monitoring the activity of neural tissue and perform some sort of external
action, taking input from a person's surroundings and modulate neural activity according
to this external input (sometimes called a neuroprosthetic device), and modulating the
activity of one area of neural tissue according to the monitored activity of another area of
the tissue. The last type of interaction for a BMI can be realized in the form of a closedloop BMI device because its interactions are solely within the brain. A BMI device,
theoretically, can use any type of device which monitors or modulates neural activity. We
decided to use Optogenetics for neural modulation and Fluorescence Imaging and ECoG
recording for monitoring when designing our optogenetic brain-machine interface.
During experiments, with our collaborators at the University of Wisconsin-Madison, we
integrated a transparent ECoG into the experimental set-up [17].

9. Neural disorders and Current Treatments
The goal of neuromodulation and Brain-Machine interface research is the ultimate
realization of real world treatments and therapies for neurological disorders, diseases, and
injuries using any of the various neuromodulation techniques. In order for
neuromodulation to be described as a therapy, defined by K. M. Alo and J. Holsheimer, it
must be an ongoing, dynamic intervention that affects specific neural networks and its
clinical effect is continuously controllable by varying stimulation parameters [18].
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Neuromodulation techniques, therefore, can include any method to alter the activity of
neurons in a controlled manner.
One of the most developed techniques is Deep Brain Stimulation (DBS) utilizing
electrodes as the method for altering neural activity. As early as 1969, chronic DBS of
the thalamus, straitium, and pallidium has been used to treat movement disorders [19]. As
research in DBS has matured, there have been therapies for essential tremors [20] and
Parkinson’s Disease [21]. Current neuromodulation therapies for epilepsy include vagus
nerve stimulation, and DBS [22]. DBS has also provided therapies for neurobehavioral
disorders such as Obsessive Compulsive Disorder and treatment-resistant depression
[22]. DBS has had success in relieving chronic pain and neuropathic pain syndromes
[22]. DBS is also being applied as therapies for Tourette’s Syndrome [23,24], obesity
[25], dementias [26][27], addictions [28], tinnitus [29], and anorexia [30]. Another type
of modulation currently used to offer treatments for the management of spasticity and
pain is chemical. Chemical modulation usually consists of devices which allow chemical
compounds to pass through the blood brain barrier [22].
While these types of neuromodulation have been successful for many types of
neurological disorders, they lack the ability to control where and which cell types they
target to modulate activity. Having the ability to stimulate specific types of neurons using
genetic targeting [15], directly inhibit neural populations [16], or precisely controlling the
modulating mechanism, similar to what is described in this thesis, could create safer
therapies for the already established therapies which use DBS, electrical, or chemical
neuromodulation. Optogenetics, using gene therapy to introduce light-gated ion channels
into neurons, has many of these advantages which could allow previously not-feasible

20

therapies to be realized. Introduced in 2005, optogenetics is still in the early stages of
developement and has yet to be fully developed. One exciting prospect is using a spatial
temporal light projection system to target cortical areas of the brain in order to
supplement loss of sensory networks which have been disrupted by brain injuries such as
those caused by stroke. The success of optogenetics will come from its natural
advantages over current techniques. It seems unlikely that current companies who are
leaders in neuromodulation device development would stop researching and furthering
the already developed electrode technologies for therapies which utilize optogenetics.
However, as long as the limitations of electrodes lags behind the potential for improved
neuromodulation therapies using optogenetics, there will be a demand to realize the true
potential of optogenetics.
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Chapter III.

Optogenetic Brain-Machine Interface Design

1. Design Overview and Design Goals
The development of a device which has the ability to monitor neural activity
and/or biological functions of tissue as well as simultaneously modulate, both inhibit and
stimulate, neural tissue with a spatial resolution of a single neuron and a temporal
resolution of an action potential will enable researchers a unique opportunity to
investigate how the brain networks process information. Understanding how networks of
neurons process, store, and recall information from our surrounding world appears to be
an important aspect of brain research.
Using the newly established field of optogenetics, we now have the ability to directly
stimulate and inhibit neurons using light. As discussed earlier, using ChR2 and blue light,
we can open ion channels which allow positive sodium ions into the cell, and using
NpHR and yellow light we can activate an ion pump which pumps negative chloride ions
into the cell. Recalling that as a neuron’s membrane potential becomes more positive it
may reach a threshold voltage at which the cell has a large membrane potential spike
caused by voltage gated ion channels. This large membrane potential spike passes the
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signal along the neuron’s axon and to the ends of the dendrites where the signal is
chemically relayed to post synaptic neurons.
Not only does using optogenetics and light provide direct and precise control of
neural tissue modulation, many optoelectronic devices have been developed over the
years and are used to modulate light spatiotemporally. Using these spatiotemporal light
modulating devices, we could imagine the possibility of being able to target specific
neurons or groups of neurons which we would like to modulate. Having an ability to
target groups of neurons opens the possibility of probing or applying inputs to targeted

Figure 4 – The future hardware design for our Brain-Machine Interface. Each section is
discussed in depth in the next section. Some features displayed in this image are not available
with the current implementation. See Figure 15 for the current progress of the device.
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neurons while avoiding surrounding non-targeted neurons.
In order to probe neural circuitry, we must be able to record the activity of these
neurons. Ideally, we would like to record the activity of all neurons simultaneously with a
temporal resolution similar to that of an action potential. Many functional fluorescence
molecules have been used to record neural activity [31]. Along with intrinsic
fluorescence molecules, such as NADH (nicotinamide adenine dinucleotide) and FAD
(flavin adenine dinucleotide), which are both involved in cell metabolism, there are
genetically expressed fluorescence molecules which can provide information about the
membrane potential, or can provide information about ion concentrations within a cell,
such as calcium indicators. Among these fluorescence molecules, some have the ability to
function on similar temporal scale as neural action potentials.
Along with using an imaging path to monitor neural activity, we can use our
imaging device to make spatial geometrical relations between the location of samples
which we are imaging and our projection path which is used to modulate the samples.
These spatial relations make possible our ability to spatially target certain areas of the
sample. Combining all of these functions: bi-directional neural modulation, monitoring
neural activity, and targeting, into one device will enable the possibility of methodically
investigating neural circuitry.

2. Device Development
A. Optogenetic Projection Path
A block diagram of the projection path of the device is illustrated in Figure 5. We
implement a high powered blue (2 Watt, 445 nm) laser for our optogenetic stimulation.
The laser beam is homogenized by an integrating rod and collimated by a telecentric
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illumination lens mechanism before exposing the active area of a Digital Micromirror
Device (DMD) through a total internal reflection (TIR) prism. The TIR prism, which is
placed in front of the DMD, guides the beam of light to illuminate the DMD surface at an
angle of 24 degrees, see Figure 6 according to the specific design of micromirrors on the
DMD chip. This prism also separates the illuminating beam from the modulated reflected
beam.
The DMD (Model – DLP Discovery 4100 0.7 XGA) consists of a 1024 by 768
matrix of tiny mirrors (13.6 micrometer pitch) which are programmatically controlled to
reflect projection light into the lens or reflect the light away from the lens. Our DMD

Figure 5 - Projection path block diagram. Laser light originates from the laser. Propagates through the
homogenizer and diffuser, and then enters the optical engine for the DMD device. The light is then
spatially modulated and projected through a telecentric lens, beamsplitter #1, and finally the
objective to the sample.
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chip can display up to 32,552 binary frames a second or 290 8-bit grayscale images [32]
[33]. This speed and high resolution allows us to display grayscale images on the same
time scale of neural activity with megapixel resolution which should allow the device to
simultaneously modulate a neuron’s activity independently. For our experiments
presented later, the DMD was used to create pulsed laser trains of spatial photostimulus
patterns. Rather than modulating the power of the laser, we set it to full power and create
the pulses by toggling the DMD, effectively creating a pulsed laser signal.
DMD systems require uniform angles of incidence across the entire modulation

Figure 6 - Digital micromirror functionality on DMD chip. Each one of the 768 by 1024 mirrors can be
independently controlled to be either on or off. The flat energy state occurs when the DMD is not
initialized. After initialization, the mirrors enter the off state.
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screen [32]. To provide this illumination, telecentric illumination architecture is
introduced directly before the DMD. In telecentric systems, the optical pupil is at infinity.
This means that the chief rays for each point in the illuminated image field are parallel
and each DMD micromirror is illuminated with a cone of light incident at the same angle.
The spatial light modulator which we integrate in our design, DLP4100 by Texas
Instruments, uses a TIR prism to systematically separate the light from the telecentric
illuminator and the light reflected by the DMD. All light rays incident on the TIR
surfaces which are below a specific incidence angle, light from the telecentric
illuminator, are reflected onto the DMD. The modulated beams are sent back to the TIR
surface at angles such that they are now transmitted through the TIR prism and into the
projection optical system.
In a projector, the illumination optical system, the modulator device, and the
projection optical system (i.e., the projection lens) form a single complex optical system.
Each of these three modules optically "interact" with each other and their respective
designs must carefully adhere to specific interface requirements. When full performance
is required, the projection lens should be designed specifically for use with a particular
illumination optical architecture. In our system, we must take into account the
illumination pupil position, the thickness of the TIR prism and the DMD mirrors, the size
and resolution of the DMD, and the f/# of the illumination system.
The modulated beam, transmitted through the TIR prism from the DMD
micromirror array, enters a telecentric lens. This telecentric lens ensures that only the
rays reflecting directly perpendicular with the DMD face enter the system. This is
important when trying to avoid areas of tissue with the photostimulus light. If light were
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able to enter the telecentric lens at an incident angle of 24 degrees, the “off” mirror angle
of the DMD, then stimulus light could possibly excite an optogenetic opsin in a nontargeted area. The projection optical system accepts these rays of light, transmits, and
refracts them in such a way as to produce an image of the DMD mirror array surface onto
a remote screen or at a suitable intermediate image plane to be captured by yet another
optical system, an image combiner (Photometrics, DC2). The telecentric lens also scales
down the image created by the DMD by a factor of 2 and projects the pattern on the
entrance pupil of the image combiner or beamsplitter #1. The image combiner is an
assembly of mirrors, lenses, and a replaceable dichroic or a beam splitter with two
polarizers (shown in Figure 5 and Figure 15 as beamsplitter #1).
Beamsplitter #1 could be any component which has the ability to separate two
separate sources of light. This component creates a junction between the optogenetic
projection path and the fluorescence imaging path. Choosing this optical component
depends solely on your experimental application.
The first consideration and most important consideration when choosing which
optical component to use for beamsplitter #1 is the type of optogenetic opsin we intend to
use during our experiments. Although many new opsins are being discovered, there is
still a limited selection available and careful consideration should be made when
choosing an opsin. Our focus when choosing an opsin, on an experimental design level, is
the opsin’s excitation wavelength and function. The excitation wavelength must be
reflected to the sample when it comes in contact with optical component #1.
The second consideration when choosing beamsplitter #1 is the fluorescence
emission wavelength which will be used for neural monitoring. Depending on the
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biological process which you would like to investigate, there are many fluorophores or
fluorescence molecules to consider. There are a wide variety of fluorophores available
which allow monitoring from many different biological processes such as, vascular
processes, metabolic processes, neural ion concentration, and cell voltage sensitive dyes,
all of which can be chosen to fit into your experimental needs.
When looking at Figure 5, one can notice that the optogenetic stimulating light is
reflected by beamsplitter #1 while, in Figure 8, the fluorescence imaging wavelength
propagates from the sample through beamsplitter #1 onto the camera’s sensor. One
optical component which has this property is a dichroic mirror. One set of beamsplitter
configurations for the projection wavelength, fluorescence emission wavelength, and
beamsplitter #1 for the device is displayed in Figure 7. We see that our blue optogenetic
stimulation light is reflected by beamsplitter #1 while our emission fluorophore
wavelength is allowed to pass through the component to the camera.
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Figure 7 - This figure illustrates an example of optical components adapted for our neurovascular
coupling experiment. Beamsplitter #1, in figure 5, reflects the selected opsin’s stimulating
wavelength (~445nm) while it allows the fluorescence emission wavelength to transmit through
toward the camera. Beamsplitter #2, in the same figure, allows for the introduction of the excitation
wavelength for Rhodamine B isothiocyanate-dextran (Sigma, 70 kDa) while also allowing both the
opsin stimulating wavelength and fluorescence emission wavelength passing through.
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B. Fluorescence Imaging Path
Fluorescence imaging requires
illuminating fluorescence molecules
with an excitation wavelength. An
excitation wavelength source provides
the energy for the fluorescence
molecule to emit light of a lower
energy level. We introduce a
beamsplitter, beamsplitter #2 in Figure
8, to deliver light of an appropriate
fluorescence excitation wavelength
into the system. This beamsplitter must
allow the fluorescence signal and the
optogenetic excitation wavelength to
pass through while reflecting the
fluorescence excitation light to the
sample. We have used one excitation

Figure 8 - Fluorescence imaging path. The excitation
light for Rhodamine B isothiocyanate-dextran (Sigma,
70 kDa) is introduced at beamsplitter #2. This
propagates to the sample. The fluorescence emission
light is captured through the objective. There is an
optical filter directly in front of the camera to
eliminate unwanted light from being imaged by the
camera.

source for each of our experiments, discussed in detail later, that involve fluorescence, a
wide-spectrum high-power light source filtered to a specific wavelength bandwidth and a
high power ultra violet (UV) LED.
The wide-spectrum high-power source produces light which passes through one
of four user specified optical filters. The optical path is controlled by a galvanometer
mirror that directs the source light to a pair of parabolic mirrors and then injected into a
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homogenizing light guide. Between these two mirrors, the light passes through a hot
mirror, to reduce the infrared power, before being filtered by the appropriate optical filter.
We use sputter-coated high-transmission fluorescence excitation filters which are capable
of withstanding the absorption of large amounts of optical power from being mounted
close to the high-power source.
As the fluorescence excitation light hits the sample, it causes the fluorescent
molecule to fluoresce emission light which corresponds to a biological process under
monitor. This emission fluorescence signal propagates from the sample through the
imaging path eventually becoming incident on an imaging sensor. As this signal
propagates through the imaging path it passes through a number of components: an
objective lens, beamsplitter #1 and beamsplitter #2, a collimating adaptor, and optical
emission filters.
To ensure the light measured by our imaging sensor is the only light from our
fluorescence emission signal, we place optical emission filters in the optical path. A high
speed filter wheel holds the emission filters in place between beamsplitter #1 and the
imaging sensor within a collimating emission adaptor.
The collimating adaptor is required for two reasons as demonstrated in Figure 9(a)
and (b). Anytime a flat piece of glass with a refractive index different from air is inserted
in a focusing beam, the beam no longer focuses at its original location; instead, the
location of the focal plane is shifted. The amount of shift depends on the thickness of the
filter as well as the index of refraction of the glass used to make the filter. The second
reason is the bandpass quality of the filter which decreases as the incident light’s angle
changes from 0 degrees. The collimating emission adaptor creates an area of collimated
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light which allows the addition of other optical devices, such as a filter wheel, without
sacrificing on the performance or introducing optical aberration, Figure 9(c).

Figure 9 - Light incident to color filters should be collimated to ensure that the imaging focal plane
is not affected by the change in refractive index of the color filters. (a) shows the shift in the focal
plane after a section of glass is introduced in to the system. (b) shows a complication which arises
from this type of aberration. (c) shows a diagram of one solution to fix this issue which is to
collimate the light before it passes through the glass section.

Many fluorescence molecules, such as NADH, have faint signals; therefore, to
improve our fluorescence detection capability, we have used an Electron Multiplying
Charge Coupled Device (EMCCD) as our fluorescence detector. We chose the
photometrics Evolve 512 EMCCD (photometrics, Tucson, AZ, USA) for its high
quantum efficiency and ease of integration into our system. The imaging sensor consists
of a 512 by 512 imaging array while each pixel is 16 by 16 micrometers. The imaging
sensor can detect light from 350nm to 900nm and at its maximum has a quantum
efficiency of >95% [34].
It is vital that the system, in particular the DMD and the EMCCD, be fully
synchronized. Any lack of synchronization could cause considerable fluctuation in
images captured by the EMCCD. This systematic error may be misinterpreted as
fluorescence changes produced by cellular activities. In order to synchronize all the
elements of this setup, we have implemented trigger coding throughout the BMI device.
Focusing of both the imaging path and projection path is achieved by a separate
lens mechanism, a microscope objective, which is mounted after beamsplitter #2. Our
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imaging device is mounted on a three dimensional translation stage in order to center the
imaged signal and fine tuning of the parfocality between the projection and imaging
paths.

3. Device Realization
The implemented optogenetic Brain-Machine Interface has demonstrated spatial
temporal modulation of neural tissue (we have only demonstrated neural stimulation
using blue light and ChR2), monitoring neural activity using fluorescence, injected dyes
(vascular response due to optogenetic stimulation) and intrinsic fluorescence (NADH and
the metabolic response due to optogenetic stimulation), and automated targeting of areas

Figure 10 - Image of the Optogenetic Brain-Machine Interface, designed and implemented in the
BIST (Biological Sciences and Technologies) Lab at the University of Wisconsin-Milwaukee, ready for
experiments at the LOCI (Laboratory for Optical and Computational Instrumentation) lab at the
University of Wisconsin-Madison
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of interest using the spatial light modulator (DMD) and simple geometric relations
between the imaging and projection paths. An actual image of the device is presented in
Figure 10.
In order to test the projection and imaging resolutions of the optogenetic BMI,
along with a BIST lab coworker (Ryan Falk), we used the 1951 Air Force Resolution
Target (Edmond Optics, Catalog # NT58-198) to measure the resolution of the imaging
path. By projecting a uniform pattern of blue light from the DMD and imaging the
fluorescence given off by the Resolution Target we were able to determine the imaging
path to have a resolution of approximately 4.38 micrometers [35]. In order to measure the
projection path's resolution, we uploaded and projected an image of the air force target
onto a uniform fluorescence sample then we recorded the fluorescence signal through the
imaging path. Using both the image captured by our camera, the size of the image
uploaded to the DMD and the BMI's magnification, we were able to determine a
projection resolution of approximately 4.9 micrometers. The recorded images during this
process are shown in Figure 11.

Figure 11 - A) The imaging path resolution. Here we imaged the Resolution Target by projecting a
uniform pattern of blue light via the projection path and recording the fluorescence signal. B) The
projection path resolution. Here we projected an image of the Resolution Target onto a uniform
fluorescence sample and recording the fluorescence signal using the BMI's imaging path.
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Figure 12 - Demonstration of projection resolution and the quality of the imaging path. A) Mask
for the projected image. Blue projection light will reflect off of the white areas towards the
telecentric lens and the black areas will be reflected away from the telecentric lens. B) The mask
is being projected onto a YFP+ brain slice fixed on a microscope slide.
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To demonstrate the combined projection and imaging capabilities of the device,
we have modulated our optogenetic excitation light to project a masked pattern onto a
YFP+ brain slice fixed on a microscope slide using a 4X microscope objective. Then, we
imaged the fluorescence emission light with our EMCCD camera. See Figure 12 for the
projection mask displayed on the DMD and the resulting fluorescence image.

Figure 13 - A) An approximate drawing of the image which is projected onto a uniform sample
during the registration process. Using geometry, the DMD coordinates of the four projected spots or
corners, and the captured image for the imaging path (B), we can make a close approximation as to
the locations of objects in images captured by the camera. This is how targeting of specific areas or
combinations of areas possible with our system.

The programming which links many devices together to function as one finely
tuned device for complex optogenetic investigation of neural circuits was programmed
using LabView and Matlab. One notable program is part of a process called
“Registration” which makes geometric relationships between the camera pixels and the
DMD pixels. Figure 13(A) is an approximate drawing of the image which is projected
onto a uniform sample during the Registration process. Using geometry, the DMD
coordinates of the four projected “spots” or “corners”, and the captured image from the
imaging path, Figure 13(B), we can make a close approximation as to the locations of
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objects in future captured images. This is how we have made targeting of specific areas
or combinations of areas within the camera’s field of view possible.
Figure 14 demonstrates the targeting ability of the optogenetic BMI.
Demonstration of automatic cell detection made possible by the registration process
which, using geometry and known projection masks, relates the camera pixels and the
DMD pixels. Figure 14(A) shows the imaged fluorescence signal from a pollen grains
sample while projecting a uniform projection pattern from the DMD, see Figure 14(C).
We then use a filtering code on the image in Figure 14(A) to automatically extract the
"objects" and generate an appropriate patterned DMD projection image using the
previously mentioned registration process which, as we can now see, provides the basis
for targeting objects in the field of view. Figure 14(C) shows a uniform DMD projection
pattern while Figure 14(D) shows a patterned DMD projection image which is built to
target the objects within the field of view optogenetic stimulation light using data from
the Registration process, see Figure 14(B).
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Figure 14 - Demonstration of automatic cell detection made possible by the registration process
which, uses geometry and known projection masks to relate the camera pixels and the DMD
micromirrors. (A) Fluorescence images of pollen grains while projecting a uniform pattern with the
DMD (C). (B) Using a filtering code, we automatically extract the "objects" from the image in part (A)
and generate an appropriate projection pattern (D). The generation of the projection pattern
requires the DMD to camera registration data.
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Figure 15 - Current block diagram which was used in the experiments which will be discussed in
chapter 4.

The current block diagram for our optogenetic Brain-Machine Interface is
displayed in Figure 15. Beamsplitter #1 and #2 can be customized for various experiments
which may use different opsins or fluorescence indicators. The camera and DMD can be
easily related to each other allowing the targeting of areas of interest. We have
demonstrated the feasibility of incorporating fiber bundles directly after the objective lens
through various experiments. In Figure 16(left) we see the projection image from the
DMD through a bundle of 16,000 optical fibers. In the same figure (middle) the same
fiber bundle is shown sitting next to a mechanical pencil for size comparison. If we
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increase the magnification of the external CCD, which is imaging the fiber bundle tip, we
can see the individual fibers. Attempting to image fluorescence through a fiber bundle is
difficult since the fluorescence signal is faint. One idea to overcome this obstacle is to use
a graded-index (GRIN) technology along with a spherical lens to provide a large
numerical aperture (NA) while keeping loss of resolution to a minimum. In general, the
larger the NA of a lens the more light it will be able to gather.

Figure 16 – Left: An image captured from a DMD projected pattern through a fiber bundle which
consists of 16,000 optical fibers. Middle: Size comparison image of the fiber bundle and a
mechanical pencil. Right: A magnified image taken of just the wheel. If you look closely you can see
the individual fibers.

4. Micro-ECoG
Our collaborators at NITRO (Neural Interface Technology Research and
Optimization) lab at the University of Wisconsin-Madison, microfabricate custom microelectrocorticography (micro-ECoG) electrode arrays for measuring the cortical local field
potentials created by the optogenetic patterned stimulation. Micro-ECoG arrays are
implanted on top of the dura matter and are therefore useful for localizing cortical activity
across the surface of the brain. Researchers at NITRO used photolithography to define 16
platinum electrode sites (150 µm diameter) in a 4x4 grid (0.5 mm site-to-site spacing).
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They selected Parylene-C, a transparent biocompatible polymer, as the electrically
insulative substrate, so that photostimuli could be applied to the cortex through the
transparent device. In chapter 4, we will be discussing many experiments which combine
both the custom designed micro-ECoG arrays and the custom built optogenetic neural
modulation DMD platform.
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Chapter IV.

BMI Experiments and Results

1. Optogenetic Neural Modulation and ECoG Recording
Our first experiments were designed with the intent to investigate the spatial and
temporal capabilities of the optogenetic BMI setup by applying a photostimulus to the
pyramidal cells in the cortex of a ChR2 positive transgenic mouse while monitoring the
effect on the local field potentials using the NITRO’s micro-ECoG array with a 3kHz
sampling frequency. NITRO’s micro-ECoG array employs platinum electrodes on a
biocompatible transparent parylene-C substrate which allows our custom built
fluorescence microscope to image the fluorescence signals from the brain tissue
underneath the ECoG. Our collaborators at NITRO lab fabricated the electrode arrays on
a transparent insulative polymer so that when implanted on top of the dura and under a
cranial window, photostimuli could still be patterned on the cortex [17]. To investigate
the spatial functionality of our optogenetic BMI device, we varied two spatial parameters,
the location and the area of the photostimulus, while keeping temporal parameter,
photostimulus duration, at 4 ms. In order to investigate the temporal potential of our
optogenetic BMI device we varied the photostimulus duration while keeping spatial
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parameters constant. We have employed a digital micromirror device that allows us to
keep the optical power constant per area and unit of time. Keeping the optical power
constant per area and time is important when attempting to quantify the stimulation
caused by a varying photostimulus.
A. Spatial Experiments
We have projected Optogenetic photostimulus patterns with both varying area and
location on the cortical areas of Thy1:ChR2/H134R-YFP mice while monitoring the local
field potential (LFP) changes using NITRO’s micro-ECoG array. These first experiments
were conducted to better understand the spatial distinction of the LFP changes caused by
the spatially varying photostimulus. We projected many different shapes as well as
complex patterns of photostimulus with which we avoided the location where the microECoG electrodes and leads were located. The electrode array is connected to a highimpedance low-noise amplifier and voltages are recorded referenced to a coil wire
implanted in the contralateral cortical hemisphere and averaged over 100 trials. In these
experiments, the cortex is stimulated by 8ms pulses of blue light produced by a 445nm
laser module which provides 4.5mW/mm2 optical power density and 2Hz repetition rate.
a. Results
Figure 17, displays the mapped cortical potentials which were evoked
optogenetically with varying spatial parameters. The potentials were of greatest
amplitude near the photostimulus location, suggesting that photostimulus-correlated
activity is primarily colocalized with the photostimulation location. Stimulating larger
cortical volumes, Figure 17(B), induced similar amplitude potentials which were spread
over a larger cortical area. In Figure 17, we have attempted to make visualization of the
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electrode data easier to digest by using a color-mapping system, or heat-maps, which uses
colors to help the reader visualize the spatial distribution of LFPs measured during these
experiments. The localization heatmaps in Figure 17 were generated with the spline
interpolation command of Matlab.

Figure 17 – Visualizations of ECoG’s electrical LFP measurements during spatial experiments. On left,
an image of the implanted ECoG overlaid with a blue square which represents the photostimulus
size and location, the white lines are the electrode measurements, and the light blue line represents
the stimulation duration. On the right, the circles represent electrodes, the blue squares represent
photostimulus size and location, and the background is a color interpolation. Dark red equates to a
larger LFP and white represents a smaller LFP. From the data, we can visualize the effects of
translating the photostimulus as well as scaling the photostimulus size. Figure also used in [64]
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B. Temporal Experiments
In order to understand how the local field potentials (LFP) change with respect to
temporal variations, we have projected optogenetic photostimulus patterns with varying
photostimulus duration while monitoring the LFP changes using a micro-ECoG array.
The temporal experiments were conducted to better understand the temporal distinction
of the LFP changes caused by varying the duration of a photostimulation. We chose three
temporal photostimulus durations: 4ms, 8ms, and 24ms.
a. Results
In Figure 18, we can observe the mapped cortical potentials which were evoked
optogenetically with varying photostimulus durations. The LFPs increased in amplitude
as the photostimulus duration was increased. Along with this increase in amplitude, the
LFPs remained elevated for a longer period of time.
C. Spatial and Temporal Experiment Controls
In order to verify that, indeed, the effect observed by the micro-ECoG array was
caused by the light activation of the ChR2 ion channels, we ran control experiments.
Having identified the photoelectric effect as a possible artifact which may affect our data
we decided to run two experiments to help rule out this artifact or show that its effect is
negligible while implanted on the cortex of a mouse. One control experiment, see Figure
19, involved implanting wild type mice with electrode to understand the effect a
photostimulus had in mice which have not been transfected with ChR2 light-gated ion
channels. The previous experiments conducted by the NITRO lab at the University of
Wisconsin-Madison studied the photoelectric effect of their transparent micro-ECoG
while it was submerged in saline solution. Their results concluded that the photoelectric

46

Figure 18 – A visualization of the temporal experiments using the optogenetic brian-machine interface. On the
right, we establish the absolute location of the electrode array, photostimulus, and camera’s field of view with
respect to the animal’s head. On the left, we can see the photostimulus’ size, shape, and location (light blue
square), the electrodes measured LFPs (red, green, and blue lines), the start of the photostimulus is located at
the blue dot, and the photostimulus duration is represented by the varying colors. The blue color is the LFP of
the 24 mS duration, the green is the LFP of the 8 mS duration, and the red is the LFP of the 4 mS photostimulus
duration.

peak was around 5 microvolts which is substantially less than the LFP recorded during
optogenetic photosimulation during our experiments; see Figure 19. Another control
experiment consisted of avoiding the electrode sites and leads with the projection light;
see Figure 20. From the micro-ECoG readings, it is clear that any artifact which may be
caused by shining light onto the micro-ECoG is negligible. The micro-ECoG
measurements and stimulation pattern projected while avoiding the micro-ECoG
electrode sites and traces are in Figure 20. These results show that the recorded potentials
were nearly the same or negligibly different, ruling out the photoelectric effect as a
substantial contributor to the results obtained.
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Figure 19 – Shows the control experiments ran for the NITRO’s transparent micro-ECoG electrodes.
A) We demonstrate the comparison of micro-ECoG measurements in-vivo between a ChR2 positive
mouse and a wild-type mouse. This micro-ECoG data clearly shows that the electrode response in
the ChR2 positive mouse is greater than that of the wild-type mouse. B) Demonstrates the
photoelectric effect of the micro-ECoG in-vitro in saline solution with varying photostimulus
duration. We can see that the effect is dependent on the duration of the photostimulus but that
the electric response is orders of magnitude smaller than what is recorded in ChR2 positive mice.
Figure adapted from [54]
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Figure 20 – A direct comparison of a photostimulus pattern which projects on the micro-ECoG
implant and a pattern which avoids the electrodes and leads of the electrodes with the
photostimulus excitation light. A) An image of the photostimulus for the solid projection. B) An
image of the photostimulus projection which avoids the electrodes and leads of the electrode. C)
Micro-ECoG LFP measurements where the green lines represent the solid projection and the yellow
lines represent the masked projection which avoids the micro-ECoG electrodes. Using this data, we
can see that the effect of avoiding the electrodes has only a small and insignificant effect on the
local field potentials. Figure adapted from [40]
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2. Closed-Loop BMI using Projection Path and micro-ECoG
It's easy to imagine the potential impact of having the ability to modulate neural
activity using feedback from a reference signal. The reference signal could be the brain
activity, blood flow, metabolic activity, or even the signal from a sensor which is
replacing a damaged sensing organ. For example, closed-loop strategies could be
beneficial in possible treatments of seizures which are an event of abnormal,
unsynchronised discharge of cortical neurons [36]. Imagine recording from an area of the
brain tissue known to have abnormal activity discharges while having the ability to
inhibit the abnormal action potentials within these seizure areas as they become
overactive. Imagine that important connections within the brain are disconnected due to
an event such as brain injury or a stroke. Could it be possible to reconnect these areas
using a device which can modulate one area of the disconnected tissue according to the
monitored activity of the other disconnected tissue area? Feedback is a necessary
component of a BMI algorithm which intends to finely adjust the activity of neurons in
the area of interest within the brain. During the following experiments, we adapted such a
feedback system using micro-ECoG readings for neural monitoring and our optogenetic
BMI platform for neural modulation.
This section consists of two experiments in which we explore two types of closedloop functionality that are potentially valuable for future BMI devices: simultaneously
controlling the activity of many areas of tissue independently and creating an "Artificial
Connection" between two areas which otherwise would have minimal neural interaction
by utilizing the spatial and temporal capabilities of the BMI.
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A. Micro-ECoG Feedback Mechanism
The feedback mechanism employed throughout the closed-loop experiments
consists of a simple negative feedback loop described in Figure 21. The most critical
parameter of the feedback mechanism is the proportionality factor, Kp. Kp is the scaling
factor for the time duration of the stimulation signal projected onto the tissue from the
DMD device. Using this simple feedback system, we were able to conduct a few closedloop experiments which monitor the local field potentials using the micro-ECoG from
NITRO’s lab and stimulating the pyramidal neurons in the cortex of transgenic mice
using our custom built DMD neural modulation platform. In Figure 22, we examine the

Figure 21 – A) A schematic of the closed-loop brain-machine interface algorithm. This closed-loop
system works by introducing an optical neurostimulating signal using the brain-machine interface
and uses NITRO’s micro-ECoG electrodes to measure the LFPs of differing areas of tissue. This
measurement is compared to a set-point and then an error signal is sent to the DMD in the form of a
analog voltage which is related to a specific photostimulus duration. B) Shows the exact algorithm
used in our closed-loop brain-machine interface. Figure adapted from [64]
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consequences of varying the value of the proportionality constant.

Figure 22 – An experiment which demonstrates the effects of varying the proportionality constant (Kp).
The top graph shows the ECoG measurements (in green), set point (in blue) with respect to time which is the
bottom axis of all graphs. The middle graph shows the duration of each photostimulus at each time. The
bottom graph displays the value selected for each Kp variable at each time. In the top graph, we can see
instances where the system is underdamped (0 s to ~250 s), overdamped (~250 s to ~350 s), and critically
damped (~350 s to ~450 s). Figure adapted from [64]

B. Multiple Area Independent Modulation
The motivation for conducting this experiment is to demonstrate an ability to
increase the neural activity of four areas by varying the photostimulus duration according
to the previous sequence's electrode signal at each location. This experiment can be
viewed as a precursor to more complicated experiment where activity levels over space
are kept at their variable set points throughout time. In these experiments, we hope to
create patterns of activity that are variable over time and space resembling the recordings
from fMRI. Due to current digital signal processing limitations, we could only read and
filter neural signals from 4 electrodes during this experiment thus limiting the number of
electrodes that could be observed in real-time.
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Figure 23 – Visualization of a complex spatio-temporal closed-loop neuromodulation experiment.
The upper left image shows the location of the photostimulus (the black square) and the
photostimulus’ related electrode number. The bottom row, which consists of three images, is the
temporal sequence of applied photostimulus projection locations. The sequence of masks applied is
as follows, projection mask #1 is available for projections for 100 ms, then projection mask #2 is
available for projections for 100 ms, then projection mask #3 is available for projections for 100 ms,
followed by a period of 700 ms when no projection mask is available for projection. This sequence is
repeated for hundreds of seconds, data of which is displayed in the top right image. The top right
image shows the measaured micro-ECoG values (in green) of all four electrodes involved in the
closed-loop experiment, the activity set-point (in blue) for each of the four electrodes, and the
photostimulus duration (in red), all through time which is the horizontal axis of the graphs. From
this data, we can see that our spatio-temporal BMI has the ability to control multiple points which
follow independent set-points over time. Figure adapted from [64]

The multiple area independent modulation experiment was designed to modulate
the activity of 4 areas of tissue around electrodes from the base level activity to
independent pre-chosen neural activity set points (see Figure 23) using feedback from
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each electrode recorded during the previous stimulation sequence. The feedback signal
allows the adjustment of our photostimulus duration, either longer or shorter, according
to the reference set points. Using feedback, we were able to raise the level of activity to
the set point level within a relative proximity of its associated set points by adjusting the
feedback parameters (see Figure 23).
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Figure 24 – (Top Image) An image visualization of the 4 point closed-loop BMI experiment. This
image consists of an intensity color (black equals little to no activity while white equals most
increased activity) for all 157 sequences of the experiment. The electrodes which correspond
to a given photostimulus are identified by the red rectangles and the square # located to the
right of the image. The middle image is a visualization of the projection sequences. The bottom
diagram is a block diagram of the electrode signal filtering and processing.
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C. “Artificial Connection” Between Two Neural Areas
The “artificial connection” experiment which I present is motivated by the ability
to connect two “sites” of the brain tissue which otherwise would not have been connected
or have been disconnected due to brain injuries or diseases. In Figure 25(a), we can view
the physical location of the two sites which we intend to “connect”. The two sites are
placed sufficiently far away from each other to minimize the cross talk of the local field
potentials picked up by the micro-ECoG electrodes. The procedure for this experiment is
as follows: Site 1 is programmed to follow a predetermined electrode activity set point
where the tissue’s activity is modulated by the optogenetic DMD stimulation platform
and the feedback system with a proportionality factor (Kp) the same as described earlier
in the multiple area independent modulation experiment. Site 2 is programmed to follow
the electrode measurement of site 1’s activity caused by the previous stimulation. This
essentially creates an artificial connection between these previously minimally connected
areas of cortical neural tissue.
Looking at Figure 25(b), we can observe the electrode measurements at site 1 and
site 2 as well as the activity set point of site 1. While observing the results in Figure
25(b), it shows that the site 1 (blue line) roughly follows the set point (black line), and we
also see that site 2 (green line), slightly lags, or follows site 1’s LFP measurement (blue
line).
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Figure 25 – The “artificial connection” experiment. This experiment is an experiment which was run
to grasp the feasibility of bypassing nonfunctioning tissue within the cortex. In this experiment, we
used a feedback system where the electrode measurements controlled the projection durations of
photostimulus. The overall process is as follows: Site 1 is programmed to follow the set-point and
site 2 is programmed to follow the electrical activity measurements from the electrode located at
site 1 thereby allowing the activity signal from site 1 to be transferred to site 2 without these two
locations being previously associated with each other. (b) It can be observed that the activity of site
1 follows the set-point, while site 2 slightly lags the activity of location 1 or location 1 follows the
electrode measurements from location 2. This figure is adapted from [64]

3. Optogenetic Investigation of Neurovascular Coupling
The experiments we designed to investigate the causal relationship between
neural activity and hemodynamics within brain tissue are of clinical and experimental
interest. Optogenetics is a great tool to investigate this relationship. A temporal
correlation has been established between LFPs and the BOLD signal recorded by fMRI
machines [37]. Another interesting result in using optogenetics to investigate the
relationship between neural activity and hemodynamics is to understand how optogenetic
stimulation relates to hemodynamics. Benefits of using the custom projection device and
optogenetics to investigate hemodynamics is the cell type specificity and a direct route to
recruiting activity as well as the spatial patterning of stimulating light. Blood flow
changes in response to optogenetic stimulation have been previously described [38]. This
experiment provides a novel approach for studying neurovascular coupling by imaging
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cerebral blood vessels in-vivo while applying photostimulation to the cortex through a
thinned-skull window in Thy1-ChR2/H134R mice [39] using the previously described
optogenetic projection device, see Figure 15, and an intravenal dye, Rhodamine B
isothiocyanate-dextrane (Sigma, 70 kDa). For more specifics on the animal protocol refer
to [40].
A. Experimental Procedure
Epifluorescence images of the cortical surface were collected at 7 frames per
second. Mirror #1, see Figure 15, was a dicroic with longpass cutoff at 500 nm. We used
a 50%-50% beam splitter for mirror #2. Rhodamine B was excited with green light
(550/40 nm, 1 mW total power) from a xenon light source (DG-4, Sutter) and a red
emission filter 630/50 nm (Chroma) was positioned in front of the camera. During each
trial, the vessels were imaged for 10 seconds prior to the photostimulus and 30 seconds
following the stimulus. The photostimulus (4.5 mW/mm2, 445 nm) was applied for 1
second and pulsed at 25 Hz (20 ms on, 20 ms off). Trials were repeated every 1 to 2
minutes, and 7 trials were done for each photostimulus pattern.
To determine vessel diameters, measurement locations were specified on each
vessel manually and a band was defined along the axis of the vessel over which the data
were spatially averaged. The vessel width was measured as the full width at halfmaximum, and a 3 point median filter and 3 Hz low pass filter were applied similar to
Drew et al. [41].
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B. Results
Branches of the middle cerebral artery (MCA) dilated transiently following
photostimulation (25 Hz x 20 ms for 1 second, 4.5 mW/mm2, 445 nm) of the cortex, see

Figure 26 – Quantification of blood vessel diameter expansion in response to optogenetic
photostimulus in ChR2 positive mice. Three spatially varying photostimulus masks were used to
stimulate the cortical neurons within a mouse (a-c, overlaid in blue). The photostimulus was applied
as a pulse train with irradiance held constant (20 mS pulsewidth at 25 hz for 1 Sec, 4.5 mW/mm2,
445nm wavelength). The average image of prestimulus recordings is shown as the gray image and
the post stimulus percent change overlaid in red (a-c). From this data, the large (a) and medium (b)
photostimuli caused the middle cerebral artery branches to dilate, while the veins showed minimal
response. (d) Arteries are labeled a1 and a2 while veins are labeled v1 and v2. (e) Measured
diameter values of the middle cerebral artery branches (a1 and a2) showed a 30% increase following
the large area photostimulus, while the medium area photostimulation caused a 15% diameter
increase, and the small photostimulus caused minimal dilation. In comparison to the arteries, the
venous response (v1 and v2) was smaller and seemed to return to basil value slower. Seven trials of
each stimulus were conducted per animal. (f) The study was replicated in 4 ChR2 positive mice and 4
wild type mice, and the median percent change of the MCA was significantly larger (p = 0.014) in the
ChR2 positive mice than in the wild type at the alpha = 0.05 confidence level (one-tailed signed rank
test). Figure adapted from [40]
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Figure 26, recovering to prestimulus diameters after several seconds. The hemodynamic
response was robust, occurring in every individual trial. While branches of the MCA
dilated more than 30% for the large photostimulus, nearby veins showed a much smaller
and somewhat delayed response.
The magnitude of both the arterial and venous response depended on the cortical
area excited optogenetically. We used the microprojector to create photostimulus patterns
of different areas while holding optical power per area (irradiance) constant. The smallest
photostimulus evoked little to no hemodynamic response, while the two larger
photostimulus patterns evoked proportionate responses.
C. Neurovascular Coupling Control Experiments
As light is absorbed by tissue, there is a transfer of energy in the form of heat.
There were concerns that this increase of tissue temperature could have introduced an
artifact. Also, some fMRI artifacts have been reported in wild-type (WT) rodents at high
photostimulus levels [42,43]. In response to these concerns, we replicated our study in
both ChR2 expressing (n=4) and WT (n=4) mice, Figure 27. The median arterial response
to the large photostimulus was significantly (p=0.014) larger in ChR2 than WT mice, see
Figure 26 and Figure 27.
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Figure 27 – Quantification of blood vessel diameter expansion in response to optogenetic
photostimulus in wild type mice. Three spatially varying photostimulus masks were used to
stimulate the cortical neurons within a mouse (a-c, overlaid in blue). The photostimulus was applied
as a pulse train with irradiance held constant (20 mS pulsewidth at 25 hz for 1 Sec, 4.5 mW/mm2,
445nm wavelength). The average image of prestimulus recordings is shown as the gray image and
the post stimulus percent change overlaid in red (a-c). From this data, there was a relatively small
arterial diameter increase for all sizes of photostimulus and the veins showed no change. (d) Arteries
are labeled a1 and a2 while veins are labeled v1 and v2. (e) A small artifact was observed following
the photostimulation, but the aplitude was always much smaller in wild type than in ChR2 positive
mice (see Figure 26). Figure adapted from [40]

We utilized the full capacity of the microprojector to investigate whether direct
photostimulation of the major cerebral vessels is responsible for the hemodynamic
response, see Figure 28. We explored this potential artifact, because if perivascular
nerves express ChR2, then a direct cholinergic mechanism could explain the optogenetic
hemodynamic response. We applied a solid photostimulus pattern, Figure 28(a), and a
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pattern with the major cerebral vessels removed, Figure 28(b). The resulting
hemodynamic responses, Figure 28(d), were similar. Had perivascular nerves been
involved, we would have expected a disproportionately smaller hemodynamic response
for pattern with vessels omitted. These experiments, see Figure 28 andFigure 29, suggest
that projection is necessary for observed hemodynamic response, and direct projection
onto the measured vessels cannot account for the observed hemodynamic response.

Figure 28 – Quantification of artifacts caused by projecting high intensity laser light directly onto the
blood vessels. (a) We projected a solid square and (b) a pattern where the blood vessels’ locations
were masked. Other photostimulus parameters were 20 mS pulsewidth at 25 hz for 1 Sec, 4.5
2
mW/mm , 445 nm were held constant. The blood vessels were measured at the locations labeled
(a1, a2, v1, and v2) in (c). (d) The hemodynamic response was similar for the solid and masked
photostimulus patterns. Figure adapted from [40]
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Figure 29 – Quantification of diameter size comparing normal projection using the optogenetic
brain-machine interface and a blank projection (or no projection) with the optogenetic BMI. The
blood vessels show no change with the DMD chip projecting no mask while the high powered laser
is still operating. This basic control demonstrates the necessity of providing blue light to the cortex
to have an optogenetic response. Figure adapted from [40]

4. Optogenetic Investigation of Neurometabolic Coupling
A. Experimental Procedure
We imaged NADH (nicotinamide adenine dinucleotide) fluorescence intensity
using standard (single photon) excitation. NADH has an excitation peak near 350 nm and
an emission peak near 450 nm. We used extremely low levels of UV (ultra violet) light to
minimize UV damage to the cortex and to avoid excitation of ChR2. 8 µW/mm2 has been
suggested previously as a safe level for prolonged in-vivo NADH imaging [44]. We used
a UV LED (365 nm, Thorlabs) and an OD1 neutral density filter (Thorlabs) to reduce the
light level to 8 µW/mm2. At this level, we observed no photobleaching of NADH, and the
light intensity is orders of magnitude below what could possibly excite ChR2. Using the
EMCCD camera made the imaging of such a faint signal possible.
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B. Results
We imaged NADH fluorescence intensity as a signature of the metabolic status of
the cortex following ChR2 photostimulation (445 nm, 4.5 mW/mm2, 5 ms x 66 Hz for 1
second). When oxidized, NADH, an endogenous fluorescent protein involved the citric
acid cycle, glycolysis and other metabolic pathways, becomes NAD+, which doesn’t
fluorescence. The NADH signal decreased by about 4% following photostimulation and
it recovered over several seconds, see Figure 30.
This effect was not observed in WT mice; see Figure 30(g) and Figure 31. Similar
to the vascular experiment, the peak amplitude of the NADH response depended on the
area of stimulation.

Figure 30 – Metabolic increase following ChR2 photostimulation. Nicoadenine dinucleotide (NADH) is
involved in cellular metabolism. When cell metabolism increases, NADH is oxidized to NAD+. NADH
fluoresces while NAD+ does not. In this experiment, we imaged this fluorescence signal before and
2
after ChR2 stimulation (5 mS pulsewidth at 66 hz for 1 second, 4.5mW/mm , 445 nm) of different
cortical areas. A large decrease in the fluorescence signal (f) of the region of interest (ROI) displayed
in (e) for the large stimulus area (d) while for the smaller photostimulus area (a) there was a smaller
response (c) within the ROI (b). 10 trials were conducted for each photostimulus pattern per animal.
The study was replicated in 3 ChR2 mice and 3 wild type mice with the peak fluorescence change for
the large photostimulus plotted in (g). A p-value of 0.05 was found for a one-tailed signed rank test.
Figure adapted from [40]
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Figure 31 – Control data for the NADH experiments using wild type mice. While projecting a small (a)
of large (d) photostimulus onto the cortex of wild type mice there was no changed observed in the
NADH fluorescence intensity (c) and (f). Blood vessels were excluded from the ROIs (b) and (e). Figure
adapted from [40]
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Chapter V.

Predicting Light Distribution within the Brain Tissue

1. Motivation
Using light-gated ion channels in optogenetic neuromodulation allows for
unprecedented spatial and temporal control of the activity of neural tissue within cortical
areas of the brain. It is known that these optogenetic light-gated ion channels require
adequate optical stimulation to cause neural spiking. Therefore, it is essential to have the
ability to predict light intensity distribution within tissue. It is important to determine,
given some optical input, which areas of tissue could receive adequate optical stimulation
power to cause an optogenetic reaction. It is also important to determine which areas will
receive inadequate optical power to cause an optogenetic reaction. Another important
consideration, while using optogenetics, is limiting optical stimulation power to levels
below the photo-bleaching or photo-damage threshold of the tissue. Finally, it is known
that biological mediums, such as the brain tissue, are inhomogeneous, turbid, and
anisotropic which introduce problems with the assumption that the tissue is homogeneous
or isotropic.
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With these considerations in mind, we have developed a procedure to extract the
optical properties of rat brain tissue. With these optical properties, we assembled a 3-D
tool with which investigators could run Monte-Carlo simulations to determine the optical
distributions within the brain tissue before applying optical neuromodulation. This
enables them to ensure that they are not damaging tissue in the stimulation area, that they
are applying adequate stimulation power to the targeted area, and also allows them to
knowingly avoid stimulating volumes of the brain tissue deemed necessary to avoid.

2. Custom Device for Extraction of Optical Properties in Brain Tissue
The optical properties of the brain tissue are typically described in publications by
three variables: the absorption coefficient, the scattering coefficient, and anisotropy factor
[45]. In order to calculate the optical properties of the tissue, we need to measure three
values from voxels within the volume of brain tissue. These measurements include
ballistic transmittance, diffuse reflectance, and diffuse transmittance [46]. The diffuse
reflectance and diffuse transmittance measurements were aquired simultaneously using
setup #1 in Figure 32 which uses two integrating spheres. This is a standard for acquiring
these measurements [47]. The ballistic measurements were obtained using the setup #2
described in Figure 32.
Our approach for measuring the necessary data to calculate the optical properties
of brain tissue required the following procedure. We scanned 500 micrometer thick slices
of fresh Sprague-Dawley rat brain tissue at a resolution of approximately 3000 points per
square centimeter for three different cuts (sagittal, transverse, and dorsal) and three
different wavelengths (405 nm, 532 nm, and 635 nm). The three different cuts cover
anisotropic factors and the three different wavelengths cover changes through the visible
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spectrum. As fresh slices were cut with a vibratome (Lancer vibratome Series 1000), we
immediately scanned the brain slices using setup #1. After scanning each slice, we
covered them with a saline solution and placed them into a fridge to preserve them. After
the whole brain was scanned, we transformed the scanning device to setup #2 and
proceeded to re-scan each slice to obtain the ballistic transmittance data. When all three
measurements were obtained, we used the inverse adding doubling (IAD) algorithm [46]
to reconstruct the optical properties from the raw data. By mapping the optical properties
to an atlas of the brain, a 3-D database of tissue optical properties was established. Next,
using this 3-D database, we ran Monte Carlo analysis to simulate light-tissue interactions
to determine the distributions of light within the brain tissue.

Figure 32 – Schematic of the experimental setups used to measure diffuse reflected and transmitted
light (Setup 1), and the transmitted ballistic light (Setup 2). This figure is directly adapted from
“Extraction of optical properties and prediction of light distribution in rat brain tissue.” [65]
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Figure 33 – The steps of Setup #2’s procedure. Part (A) shows an image taken at the beginning of
each ballistic experiment. Image processing is applied to the image to extract the slice. Software
was developed to find which voltages to apply to the galvo mirrors which then are fed into scanning
software. There are either 16 or 25 images taken during the scanning of each slice, see (B). Part (B)
shows the ballistic data which is automatically extracted using developed software. All of the data
for each slice is combined and interpolated to get an image, see part (C). Each successive slice can
then be stacked to create a three dimensional database, see part (D).

3. Monte Carlo Light Distribution Simulations
In Figure 36, we ran simulations by employing our 3-D Monte Carlo toolbox [47,48]
to demonstrate the effects of using different light delivery parameters such as the optical
fiber diameter, wavelength, optical fiber numerical aperture (NA), and the beam profile
of the light source, see Figure 36. We ran simulations using the Monte Carlo toolbox to
present the impact on axial fluence at varying depths by placing an optical source at
different locations on the cortex of the brain tissue. The simulation results are shown in
Figure 35.
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Figure 34 – A visualization of a Monte Carlo simulation overlaid onto the corresponding slice within
a brain atlas.

Figure 35 – (A) Optical fibers with 100 micrometer diameters are placed on the regions marked ‘A’
and ‘B’. (B) Using data obtained in these extraction experiments, we can simulate the axial fluence
rate along the z axis for different locations of the brain, in this case, ‘A’ and ‘B’. The difference
between the attenuation coefficients in these locations causes significant difference in the depth
which the 405nm blue laser light could penetrate. This figure is directly adapted from “Extraction
of optical properties and prediction of light distribution in rat brain tissue.” [65]

70

Figure 36 – (A) shows the location an optical fiber which is being used as an input parameter for
monte carlo simulatation software that implements our measured tissue properties which is used to
investigate the effect of source parameters on the distribution of light within the brain tissue for
405nm laser light. (B) shows the effect of varying fiber diameters, (C) shows the effect of varying
fiber numerical apertures (NA), (D) shows the effects of varying laser wavelengths, and (E) shows
the effect of the beam profile on the axial distribution of light. This figure is directly adapted from
“Extraction of optical properties and prediction of light distribution in rat brain tissue.” [65]
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Chapter VI.

Outlook for Optogenetic BMI devices and Experiments

1. Benefits of using light-gated ion channels for neuromodulation
Optogenetics has quickly become a well-known and widely used
neuromodulation technique for the study of the nervous system in animal models. The
success of optogenetics could be attributed to the large number of advantages this
technique offers compared with classical techniques, such as chemical [50] and electrical
stimulation [50,51]. The optogenetic technique allows for cell-type specific targeting [15]
by using appropriate promoters. Another benefit of optogenetics is having the ability to
bi-directionally control the cellular activity of neurons directly. By expressing both lightgated cation channels and light-gated anion pumps into neurons simultaneously, one can
either increase or suppress neural activity [14,16]. Another benefit of using light for
activating neurons lies within our technological tools which have been developed to
manipulate light to form images or spatiotemporal patterns. As the design of these
optogenetic BMIs are improved, they will play an important role in the development of
complex experiments which add to our understanding of the brain. These devices will
allow scientists to investigate neural circuitry in new ways and create complex treatments
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for brain conditions where stimulation or inhibition is needed on the cortical surface.
Examples of treatments where optogenetic BMIs could surpass current treatment
technologies are allowing profoundly blind patient sight or enabling movement in
severely immobilized limbs caused by brain malfunctions [53]. These deficits require
complex neuromodulation in order to replicate the sensory input or the physical output of
a normally functioning brain. Electrode arrays, which are currently being used for these
purposes, have severe limitations which can be avoided by using optogenetics as the
source of neuromodulation. As electrodes are implanted, they can cause a considerable
amount of damage to the brain tissue. Limitations within the manufacturing process set
limits on how many electrodes can be mounted onto a chip and how small the electrodes
can be. In the next section I will introduce some light deliver systems which could be
used in future optogenetic BMIs.

2. Future Optogenetic BMI designs and Experiments
There have been many light delivery mechanisms introduced as potential future

Figure 37 – Various techniques and devices developed or currently being developed to deliver light
to areas within the brain in-vivo. (a) shows a basic implantation of a fiber optic in brain tissue in
order to deliver therapeutic optogenetic light to areas deep within brain tissue. (b) shows a rat
which has two implants. (c) shows the structure of a multichannel waveguide [57], and (d) shows
an array of multichannel waveguides [56]. (e) shows a side-firing fiber which uses refraction to
radiate light at near orthogonal angles (developed at BIST labs) [55]. (f) and (g) show a
microactuator assembly which is able to translate optical fibers to different depths within brain
tissue [55]. This figure is directly adapted from “Optogenetic brain interfaces.” [54]
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delivery mechanisms for varying experimental and procedural applications [54]. The
simplest mechanism is a single optical fiber implanted stereotactically into target areas
either shallow or deep within the brain, see Figure 37(a and b). By altering the tip of the
optical fiber, one can direct the optical power nearly orthogonal to the fiber so that light
is emitted in a side firing fashion, see Figure 37(e) [55]. This would be valuable where a
treatment calls for stimulation or inhibiting light which is needed at different depths in
the brain. Adding multiple optical fibers together or creating multiple channel
waveguides introduces one could introduce different wavelengths in different areas or
different depths [55,56]. This would be valuable where a treatment calls for differing
stimulation or inhibiting light sources are needed at different depths or locations within
the brain. Micro-actuator assemblies have been developed to move side firing fibers
inside the brain in a direction perpendicular to the surface of the skull, see Figure 37(f
and g) [55]. This device was designed to be used with some type of side-firing optical
fiber so that one could modulate different layers within the brain.
Continuing to more complicated designs, we examine spatial light modulator
(SLM) systems which include the device introduced in this thesis. Using these light
modulating devices one can directly target areas on the surface of the cortex with great
spatial and temporal resolution. As introduced in this thesis, one could develop a system
which utilizes a DMD SLM, see Figure 38(a). Another SLM which was not introduced is
liquid crystal technology which is fundamentally designed to be used with coherent light
sources. These light modulators work by introducing a spatial phase shift which, in turn,
introduces interference patterns creating spatially varying levels of optical power. For a
simple block diagram of a liquid crystal design, see Figure 38(b). The block diagram
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presented displays SLM systems which couple with fluorescence imaging systems to
allow for monitoring of introduced opsins and/or monitoring the neural activity within the
field of view. Advances in SLM technology could allow for the miniaturization of these
designs allowing systems small enough to be feasibly implanted onto the surface of the
skull allowing a patient the ability to be actively moving while wearing the optogenetic
BMI device.

Figure 38 – Two different spatial light modulator designs for optogenetic modulation. (a) shows a
design for a DMD based system for both optogenetic modulation and fluorescence and wide field
imaging. This is the design which was implemented in this thesis. (b) shows a design for a liquid
crystal based system for optogenetic light delivery and holographic microscopy. This figure is
directly adapted from “Optogenetic brain interfaces.” [54]
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Developing a device which combines projection technologies with brain imaging
systems allows for many more brain-machine interface device designs. Initial imaging
devices used in neuroscience measured the electrical activity of the brain tissue. Over
time, these technologies have evolved to more complex and accurate measuring tools. As
stated earlier, patch clamp technology allows for the measurement of the membrane
potential form a single neuron. An electrode can measure the local field potential of the
surrounding tissue while an array of electrodes can measure multiple LFPs within tissue.
Moving from electrodes to more abstract measurement techniques, fluorescent indicators
fluoresce with different intensities depending upon the electric potential. As presented in
this thesis, one could use blood flow or blood vessel diameter as an indicator of neural
activity as well as intrinsic fluorescent molecules which are directly involved in cell
metabolism such as NADH or FAD.
Combining these many types of optogenetic neuromodulation techniques with the
many brain imaging systems opens possibilities for new experiments. These new
experiments could help to provide insight into the workings of neural circuits, neural
function, or maybe neural circuit development. Using optogenetic modulation while
monitoring activity within the brain using fMRI could be of great importance for a simple
fact that fiber optics are compatible with the fMRI design. With optogenetic research in
its infancy, there are many opportunities to think of novel experiments which could prove
to be of great importance to neuroscience and the collective understanding of how our
brains function.
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Chapter VII.

Concluding Remarks

The optogenetic brain-machine interface and light distribution simulation tools
developed during my collaboration with the Laboratory of Optical and Computational
Instrumentation (LOCI), Neural Interface Technology Research Optimization Laboratory
(NITRO), and members of the Bio-Inspired Sciences and Technologies laboratory
(BIST). Notably, from BIST labs, Mehdi Azimipour, Ryan Falk, and of course, my
advisor and mentor, Dr. Ramin Pashaie, from LOCI and NITRO labs, Thomas Richner,
Sarah Brodnik, Dr. Kevin Eliceiri, and Dr. Justin Williams. These individuals have
helped address some of the important issues which face optogenetics as well as
developing complex BMI systems which could someday provide robust therapeutic
benefits to many people suffering from debilitating neurological diseases, disorders, and
brain injuries.
These initial device designs have shown that many complex spatiotemporal
closed-loop control therapies for addressing brain malfunctions are feasible. With some
technological advances in imaging and SLM technology, we could possibly design
systems for mobile use where a patient could carry the corrective BMI with them as they
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conduct their daily tasks. Along with the potential future therapeutic benefits of this
research, there are many scientific questions which could be addressed by employing a
similar device to our optogenetic BMI. One possible area of scientific research which
could be investigated clearly and on a timescale equivalent to that of neural activity by
using optogenetics, is the interactions between neurons within complex circuits in-vitro.
Another interesting area of research which has become possible more feasible by
employing a optogenetic BMI device is the construction of neural circuits, in-vitro, using
patterned stimulation and inhibition to develop a pre-determined desired signal
processing system. This type of research would be very similar to the work being
conducted at the Potter Lab of Georgia Tech [58], which utilize electrode arrays to build
connections and computational networks within populations of neurons. Instead of using
electrodes to build these networks in-vitro the investigator would use an optogenetic BMI
device similar to the one presented in this thesis which has spatial-temporal control of the
stimulation and inhibition of neurons in the field of view.
Another future application of the optogenetic BMI, given many technological
advances in miniaturizing the imaging and projection devices, is a device which
communicates directly to the cortex of the brain. This could include using a device to
bypass the early sensors and circuits in the visual, motor, audio, or other sensory systems.
There are currently devices which utilize electrodes to do restorative therapies which
bypass human sensors and early brain circuits to provide artificial visual stimulation to
patients who have lost their visual organs [59].
By employing the use of the Monte Carlo light distribution toolbox, one can be
sure to only alter or affect the neural activity of targeted brain tissue areas for
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experiments where optogenetics is employed. Although our initial Monte Carlo toolbox
will only use Sprague-Dawley rats, the same or a similar device can be used to extract the
optical properties of other tissues.
While optogenetics is only in the early stages of developement, the
spatiotemporal optogenetic BMI and the Monte Carlo toolbox for predicting light
distribution within the brain tissue address some of the concerns and technological
questions which, until now, have been unanswered.
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